We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App

AI Model for PET Imaging Determines Patient Response to Brain Tumor Treatments

By MedImaging International staff writers
Posted on 21 Aug 2023
Print article
Image: An AI model can evaluate brain tumors on PET (Photo courtesy of Freepik)
Image: An AI model can evaluate brain tumors on PET (Photo courtesy of Freepik)

The assessment of changes in metabolic tumor volume (MTV) through PET scans using specific radiotracers like F-18 fluoroethyl tyrosine (FET) plays a vital role in evaluating the treatment response in patients with brain tumors. Conventionally, MTV is determined through manual or semiautomatic processes, which are not only time-consuming but may also vary depending on the clinician performing the task. Now, a new AI model for PET imaging could greatly assist clinicians in evaluating how patients are responding to brain tumor treatments.

Researchers at Aachen University Hospital (Aachen, Germany) demonstrated that a deep learning-based AI model can automate the segmentation of MTV on brain PET images, potentially eliminating the need for human clinicians to preprocess these images. The goal of their study was to create a method for automated MTV segmentation and assess its effectiveness in gauging treatment responses in glioma patients. The research included a collection of 699 F-18 FET-PET scans from 555 brain tumor patients, either obtained at the time of initial diagnosis or during subsequent follow-up visits. Experienced nuclear-medicine physicians first segmented the MTV in these images, encompassing lesions with varying levels of F-18 FET radiotracer uptake.

The team then utilized 476 of these images to train an AI neural network, named "no new U-Net," to perform MTV segmentation. To evaluate the model's accuracy, they applied it to an imaging dataset consisting of 223 scans from 156 different patients. Out of 205 lesions showing increased F-18 FET uptake in this dataset, the model correctly identified 189. Interestingly, the model did not mistakenly identify any anatomic regions with normal increased uptake of F-18 FET radiotracer, such as in the superior sagittal sinus, as tumors. The model's performance was quite remarkable, achieving a mean F1 score of 92%, a sensitivity of 93%, and a positive predictive value of 95% in detecting lesions. A key advantage of this model is its ability to fully automate 3D segmentation using just a single F-18 FET-PET scan. Moreover, it can perform this task in under two minutes using a standard graphics processing unit, without the need for any preprocessing.

"The main finding of our study is that our deep learning-based neural network allows reliable and fully automated detection and 3D segmentation of brain tumors investigated by F-18 FET PET," noted the researchers. "This finding highlights the value of the network for improvement and automatization of clinical decision-making based on the volumetric evaluation of amino acid PET."

Related Links:
Aachen University Hospital 

Gold Supplier
128 Slice CT Scanner
Supria 128
Gold Supplier
Conductive Gel
Diagnostic Ultrasound System
DRE Crystal 4P
Color Doppler Ultrasonic Scanner

Print article
Sun Nuclear -    Mirion



view channel
Image: The AI model improves tumor removal accuracy during breast cancer surgery (Photo courtesy of UNC School of Medicine)

AI Model Analyzes Tumors Removed Surgically in Real-Time

During breast cancer surgery, the surgeon removes the tumor, also known as a specimen, along with a bit of the adjacent healthy tissue to ensure all cancerous cells are excised. This specimen is then X-rayed... Read more


view channel
Image: MRI screen-detected breast cancers have been found to be most often invasive cancers (Photo courtesy of 123RF)

MRI Screen-Detected Breast Cancers Are Mostly Invasive

Annual breast MRI screening is advised for patients with a lifetime breast cancer risk exceeding 20%. There exists robust data about the features of mammographic screen-detected breast cancers, although... Read more


view channel
Image: FloPatch is a revolutionary tool that facilitates real-time precision in IV fluid management in sepsis (Photo courtesy of Flosonics)

Wireless, Wearable Doppler Ultrasound Revolutionizes Precision Fluid Management in Sepsis Care

When a patient comes to the hospital with sepsis, administering intravenous (IV) fluids is usually the first course of action. However, too much IV fluid can do more harm than good, causing additional... Read more

General/Advanced Imaging

view channel
Image: Annalise Enterprise CTB acts like a ‘second pair of eyes’ for radiologists (Photo courtesy of Annalise.ai)

Deep Learning System Boosts Radiologist Accuracy and Speed for Head CTs

Non-contrast computed tomography of the brain (NCCTB) is a commonly employed method for identifying intracranial pathology. Despite its frequent use, the complex scan outcomes are prone to being misunderstood.... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.